HCC: The role of immunotherapy beyond advanced HCC

December 06, 2023 • 00:29:42
HCC: The role of immunotherapy beyond advanced HCC
COR2ED - Oncology Medical Conversation
HCC: The role of immunotherapy beyond advanced HCC

Dec 06 2023 | 00:29:42

/

Show Notes

In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced and early stage hepatocellular carcinoma (HCC).  They focus on the role of immunotherapy and review data from three major congresses in 2022 (ASCO, WCGIC and ILC) together with recent publications. 

Prof. Amit Singal is Director of Liver Cancer Program at UT Southwestern Medical Center, Dallas, TX, USA and Assoc. Prof. Neil Mehta is Director of Liver Cancer Program at University of California San Francisco, USA.

Other Episodes

Episode

December 06, 2023 • 00:19:51
Episode Cover

Advanced RCC: Clinical implementation of targeted therapies and immunotherapies

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of...

Listen

Episode

December 06, 2023 • 00:29:25
Episode Cover

Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial...

Listen

Episode

December 06, 2023 • 00:27:20
Episode Cover

Managing thrombosis: Part 2 - Cancer and thrombosis

In this podcast episode, Prof Dimitrios Tsakiris (Haematologist, Basel University, Switzerland) and Dr Lars Asmis (Haematologist, University of Zurich, Switzerland) discuss the association between...

Listen